Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of 2.5% M605108 for acne vulgaris
jRCT2031200251Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of benzoyl peroxide in acne vulgaris (2 arms), sponsored by Maruho Co., Ltd. Primary endpoint: Percentage change in total lesion count from baseline to week 12. Started Nov 2020; status: completed.
02
Drugs
benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCT2031200251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200251.